Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Protein kinase Cδ controls self-antigen-induced B-cell tolerance

Nature volume 416, pages 860–865 (2002)Cite this article

Abstract

Interaction of a B cell expressing self-specific B-cell antigen receptor (BCR) with an auto-antigen results in either clonal deletion or functional inactivation1,2,3. Both of these processes lead to B-cell tolerance and are essential for the prevention of auto-immune diseases. Whereas clonal deletion results in the death of developing autoreactive B cells, functional inactivation of self-reactive B lymphocytes leads to complex changes in the phenotype of peripheral B cells, described collectively as anergy1,2,3. Here we demonstrate that deficiency in protein kinase Cδ (PKC-δ) prevents B-cell tolerance, and allows maturation and terminal differentiation of self-reactive B cells in the presence of the tolerizing antigen. The importance of PKC-δ in B-cell tolerance is further underscored by the appearance of autoreactive anti-DNA and anti-nuclear antibodies in the serum of PKC-δ-deficient mice. As deficiency of PKC-δ does not affect BCR-mediated B-cell activation in vitro and in vivo, our data suggest a selective and essential role of PKC-δ in tolerogenic, but not immunogenic, B-cell responses.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Lymphocyte development and auto-antibody production in the absence of PKC-δ.
Figure 2: Defective anergy induction in the absence of PKC-δ.
Figure 3: Activation of B cells in vitro.
Figure 4: BCR-mediated signalling in B cells of PKC-δ-/- mice.

Similar content being viewed by others

References

  1. Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682 (1988).

    Article  ADS  CAS  Google Scholar 

  2. Nemazee, D. A. & Burki, K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562–566 (1989).

    Article  ADS  CAS  Google Scholar 

  3. Hartley, S. B. et al. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353, 765–769 (1991).

    Article  ADS  CAS  Google Scholar 

  4. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607–614 (1992).

    Article  ADS  CAS  Google Scholar 

  5. Le Good, J. A. et al. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042–2045 (1998).

    Article  ADS  CAS  Google Scholar 

  6. Watanabe, T. et al. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-δ subspecies. Proc. Natl Acad. Sci. USA 89, 10159–10163 (1992).

    Article  ADS  CAS  Google Scholar 

  7. Mischak, H. et al. Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268, 6090–6096 (1993).

    CAS  PubMed  Google Scholar 

  8. Emoto, Y. et al. Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J. 14, 6148–6156 (1995).

    Article  CAS  Google Scholar 

  9. Ghayur, T. et al. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184, 2399–2404 (1996).

    Article  CAS  Google Scholar 

  10. Leitges, M. et al. Exacerbated vein graft arteriosclerosis in protein kinase Cδ-null mice. J. Clin. Invest. 108, 1505–1512 (2001).

    Article  CAS  Google Scholar 

  11. Hippen, K. L., Tze, L. E. & Behrens, T. W. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191, 883–890 (2000).

    Article  CAS  Google Scholar 

  12. Prodeus, A. P. et al. A critical role for complement in maintenance of self-tolerance. Immunity 9, 721–731 (1998).

    Article  CAS  Google Scholar 

  13. Fulcher, D. A. et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J. Exp. Med. 183, 2313–2328 (1996).

    Article  CAS  Google Scholar 

  14. Healy, J. I. et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6, 419–428 (1997).

    Article  CAS  Google Scholar 

  15. Leitges, M. et al. Immunodeficiency in protein kinase C β-deficient mice. Science 273, 788–791 (1996).

    Article  ADS  CAS  Google Scholar 

  16. Kang, S. W. et al. PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 20, 5692–5702 (2001).

    Article  CAS  Google Scholar 

  17. Doerre, S. & Corley, R. B. Constitutive nuclear translocation of NF-κB in B cells in the absence of IκB degradation. J. Immunol. 163, 269–277 (1999).

    CAS  PubMed  Google Scholar 

  18. Glynne, R. et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature 403, 672–676 (2000).

    Article  ADS  CAS  Google Scholar 

  19. Chan, V. W. et al. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J. Exp. Med. 188, 93–101 (1998).

    Article  CAS  Google Scholar 

  20. Nolan, G. P., Fiering, S., Nicolas, J. F. & Herzenberg, L. A. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-d-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl Acad. Sci. USA 85, 2603–2607 (1988).

    Article  ADS  CAS  Google Scholar 

  21. Metzger, D. W., Ch’ng, L. K., Miller, A. & Sercarz, E. E. The expressed lysozyme-specific B cell repertoire. I. Heterogeneity in the monoclonal anti-hen egg white lysozyme specificity repertoire, and its difference from the in situ repertoire. Eur. J. Immunol. 14, 87–93 (1984).

    Article  CAS  Google Scholar 

  22. Smith-Gill, S. J. et al. Mapping the antigenic epitope for a monoclonal antibody against lysozyme. J. Immunol. 128, 314–322 (1982).

    CAS  PubMed  Google Scholar 

  23. Miyake, K., Yamashita, Y., Hitoshi, Y., Takatsu, K. & Kimoto, M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180, 1217–1224 (1994).

    Article  CAS  Google Scholar 

  24. Yamashita, Y. et al. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells. Immunology 85, 248–255 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Lipford, G. B. et al. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur. J. Immunol. 27, 2340–2344 (1997).

    Article  CAS  Google Scholar 

  26. Kozono, Y. et al. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160, 1565–1572 (1998).

    CAS  PubMed  Google Scholar 

  27. Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131–137 (1994).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank C. Goodnow, J. Cyster and F. Finkelman for providing reagents; members of the Laboratory for Lymphocyte Signaling in Cologne for technical assistance; and G. Hannon for the preparation of the manuscript. We thank M. Nussenzweig, D. O′Carrol, K. Rajewsky and C. Schmedt for discussion. This work was supported by The Irene Diamond Fund (A.T.) and National Institutes of Health grant (N-Y.Z. and A.T.), S. L. E. Foundation (K.S.), Graduiertenkolleg from the Deutsche Forschungsgemeinschaft, and The Rockefeller University's Women & Science Fellowship Program (I.M.).

Author information

Authors and Affiliations

  1. Laboratory of Lymphocyte Signaling, The Rockefeller University, New York, 10021, New York, USA

    Ingrid Mecklenbräuker, Kaoru Saijo, Nai-Ying Zheng & Alexander Tarakhovsky

  2. Max Planck Institute for Experimental Endocrinology, Hannover, D-30625, Germany

    Michael Leitges

Authors
  1. Ingrid Mecklenbräuker
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Kaoru Saijo
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Nai-Ying Zheng
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Michael Leitges
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Alexander Tarakhovsky
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Alexander Tarakhovsky.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mecklenbräuker, I., Saijo, K., Zheng, NY. et al. Protein kinase Cδ controls self-antigen-induced B-cell tolerance. Nature 416, 860–865 (2002). https://doi.org/10.1038/416860a

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/416860a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing